Puma Biotech Owes $22M For Libel In Proxy Fight, Jury Says
A North Carolina federal jury has found that Puma Biotechnology Inc. defamed Pharmaceutical Product Development LLC's former CEO during a proxy fight by telling the public he had been "involved in...To view the full article, register now.
Already a subscriber? Click here to view full article